Page last updated: 2024-08-21

porfiromycin and Adenocarcinoma

porfiromycin has been researched along with Adenocarcinoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, LH; Izbicki, RM; Vaitkevicius, VK1
Brattain, MG; Casazza, AM; Long, BH; Lorico, A; Wang, L; Wang, RC1
Selawry, OS1
al-Sarraf, M; Izbicki, R; Reed, ML; Vaitkevicius, VK; Vaughn, CB1

Reviews

1 review(s) available for porfiromycin and Adenocarcinoma

ArticleYear
Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.
    Cancer chemotherapy reports. Part 3, 1973, Volume: 4, Issue:2

    Topics: Adenocarcinoma; Alkylating Agents; Antineoplastic Agents; Carcinoma, Bronchogenic; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Floxuridine; Humans; Hydroxyurea; Lung Neoplasms; Mechlorethamine; Methotrexate; Mitomycins; Nitrosourea Compounds; Plicamycin; Porfiromycin; Procarbazine; Streptonigrin; Thiotepa; Vinblastine

1973

Trials

2 trial(s) available for porfiromycin and Adenocarcinoma

ArticleYear
Phase II study of profiromycin vs mitomycin-C utilizing acute intermittent schedules.
    Medical and pediatric oncology, 1976, Volume: 2, Issue:2

    Topics: Abdominal Neoplasms; Adenocarcinoma; Female; Gastrointestinal Neoplasms; Humans; Injections, Intravenous; Male; Mitomycins; Ovarian Neoplasms; Porfiromycin; Prospective Studies; Remission, Spontaneous

1976
Further clinical trials with porfiromycin (NSC-56410) (large intermittent doses).
    Cancer chemotherapy reports, 1972, Volume: 56, Issue:5

    Topics: Adenocarcinoma; Adult; Anemia; Astrocytoma; Blood Cell Count; Blood Platelets; Carcinoma; Carcinoma, Squamous Cell; Child; Clinical Trials as Topic; Cystadenoma; Female; Humans; Leukocyte Count; Neoplasms; Osteosarcoma; Porfiromycin; Rhabdomyosarcoma

1972

Other Studies

1 other study(ies) available for porfiromycin and Adenocarcinoma

ArticleYear
Mechanisms of resistance to etoposide and teniposide in acquired resistant human colon and lung carcinoma cell lines.
    Cancer research, 1991, Oct-01, Volume: 51, Issue:19

    Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Cell Line; Colonic Neoplasms; DNA; DNA Damage; DNA Probes; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Humans; Immunoblotting; Lung Neoplasms; Membrane Glycoproteins; Molecular Sequence Data; Neoplasm Proteins; Porfiromycin; RNA; Teniposide

1991